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including sodium salicylate, cyclooxygenase (COX)2 
inhibitors (i.e., celecoxib), corticoids and prostaglandins 
as well as phytomedical products inhibit NF-κB activity 
and thus, may be of benefit in BSS.[9] However, their 
possible clinical efficacy remains to be elucidated.
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Cylindroma of the scalp
Sir,
A 56-year-old woman presented with a long-standing 
history of slow-growing multiple scalp nodules. 
Her daughter and aunt also had a history of similar 
cutaneous lesions. Physical examination revealed 
multilobulated, large, epiphytic pink nodules, 2.5 cm by 
6 cm in the greatest dimension, on the scalp [Figure 1]. 
The nodules were painless, solid, and movable from the 
underlying surface. Results of the routine laboratory 
examinations were normal. The histopathology of the 
scalp nodule revealed a well-defined dermal lesion 
composed of islands and cords of dark basaloid cells 
arranged in a jigsaw puzzle-like pattern and separated 
by hyaline basement membrane material, which was 
suggestive of cylindroma [Figure 2]. This patient 
underwent staged procedures, with debulking surgery 
followed by contouring with split-thickness skin graft. 
After 1 year, she was lost to follow-up.
Cylindromas are benign skin appendage tumors. 
They can be seen in conjunction with spiradenomas 
and trichoepitheliomas, and this condition is known 
as Brooke-Spiegler syndrome (BSS).[1] BSS is a rare 
autosomal dominant disorder caused by mutations of 
the cylindromatosis gene (CYLD) located at 16q12-q13.[2] 
The penetrance of the gene has been estimated to be 
between 60% and 100%.[3] Histologically, the tumors 
are circumscribed, nonencapsulated dermal nodules 
composed of islands and cords of basaloid cells 
surrounded by a thick, hyalinized, periodic acid-
Schiff (PAS)-positive basement membrane. The cells 
are arranged in an interlocking “jigsaw-puzzle”-like 
architecture.[4]
Treatment options in BSS are mainly for cosmetic 
concern. For solitary tumors, surgical excision is the 
treatment of choice. Other forms of therapy include 
electrodesiccation, curettage, cryosurgery, and excision 
with the use of carbon dioxide or neodymium-doped 
yttrium aluminum garnet; Nd:Y3Al5O12 (Nd:YAG) 
laser.[5,6] Topical 5% imiquimod cream has been 
advocated as a useful treatment.[7] Recently, it was 
suggested that targeting nuclear factor (NF)-κB in 
cylindroma therapy may be of therapeutic potential 
in patients with multiple tumors in the course of BSS. 
In one case of familial trichoepitheliomas, significant 
improvement was achieved with a combination of 
adalimumab and aspirin. This combination was chosen 
in order to block tumor necrosis factor alpha (TNFα)-
induced activation of NF-κB at two different levels of 
the signaling pathway.[8] Several therapeutic agents 
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Figure 1: Physical examination revealed multilobulated large epiphytic pink 
nodules, 2.5 cm by 6 cm in the greatest dimension, on the scalp
Figure 2: The histopathology of the scalp nodule revealed a well-defined 
dermal lesion composed of islands and cords of dark basaloid cells arranged 
in a jigsaw puzzle-like pattern
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